F. Rajamohan et al., High-level expression and purification of biologically active recombinant pokeweed antiviral protein, PROT EX PUR, 16(2), 1999, pp. 359-368
Pokeweed antiviral protein (PAP) from the leaves of the pokeweed plant, Phy
tolacca americana, is a naturally occurring single-chain ribosome-inactivat
ing protein, which catalytically inactivates both prokaryotic and eukaryoti
c ribosomes. The therapeutic potential of PAP has gained considerable inter
est in recent years due to the clinical use of native PAP as the active moi
ety of immunoconjugates against cancer and AIDS. The clinical use of native
PAP is limited due to inherent difficulties in obtaining sufficient quanti
ties of a homogenously pure and active PAP preparation with minimal batch t
o batch variability from its natural source, Previous methods for expressio
n of recombinant PAP in yeast, transgenic plants and Escherichia coil have
resulted in either unacceptably low yields or were too toxic to the host sy
stem. Here, we report a successful strategy which allows high level express
ion of PAP as inclusion bodies in E. coil. Purification of refolded recombi
nant protein from solubilized inclusion bodies by size-exclusion chromatogr
aphy yielded biologically active recombinant PAP (final yield: 10 to 12 mg/
L). The ribosome depurinating in vitro N-glycosidase activity and cellular
anti-HIV activity of recombinant PAP were comparable to those of the native
PAP. This expression and purification system makes it possible to obtain s
ufficient quantities of biologically active and homogenous recombinant PAP
sufficient to carry out advanced clinical trials. To our knowledge, this is
the first large-scale expression and purification of biologically active r
ecombinant PAP from E. coil. (C) 1999 Academic Press.